|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:analyzes
|
Genomic Data
Chemical Structures
|
|
gptkbp:applies_to
|
Pharmaceutical Research
|
|
gptkbp:can_be_used_to
|
gptkb:Natural_Language_Processing
|
|
gptkbp:can_lead_to
|
Cost Reduction
New Therapeutics
|
|
gptkbp:can_streamline
|
gptkb:Research_and_Development
|
|
gptkbp:can_transform_into
|
Traditional Drug Discovery Methods
|
|
gptkbp:collaboration
|
Computer Science and Biology
|
|
gptkbp:enhances
|
Patient Outcomes
Regulatory Compliance
Target Identification
Molecular Dynamics Simulations
Drug Repurposing
Collaboration between Researchers
|
|
gptkbp:facilitates
|
Personalized Medicine
|
|
gptkbp:field
|
Computational Biology
|
|
gptkbp:has_a_focus_on
|
Venture Capital Investment
|
|
gptkbp:has_achieved
|
gptkb:Side_Effects
Drug Efficacy
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
AI for Drug Discovery
|
|
gptkbp:improves
|
Drug Development Process
|
|
gptkbp:integrates_with
|
Clinical Data
|
|
gptkbp:involves
|
Predictive Modeling
|
|
gptkbp:is_a_growing_area_in
|
Pharmaceutical Technology
|
|
gptkbp:is_a_key_component_of
|
Future Drug Development Strategies
|
|
gptkbp:is_a_solution_for
|
Complex Biological Problems
|
|
gptkbp:is_a_subject_of
|
Patents
Scientific Publications
|
|
gptkbp:is_affected_by
|
Ethical Considerations
|
|
gptkbp:is_associated_with
|
gptkb:High-Throughput_Screening
|
|
gptkbp:is_based_on
|
gptkb:Artificial_Intelligence
|
|
gptkbp:is_characterized_by
|
Interdisciplinary Collaboration
|
|
gptkbp:is_evaluated_by
|
Regulatory Agencies
|
|
gptkbp:is_funded_by
|
Government Grants
|
|
gptkbp:is_influenced_by
|
gptkb:Artificial_Neural_Networks
gptkb:Big_Data
|
|
gptkbp:is_optimized_for
|
Lead Compounds
|
|
gptkbp:is_part_of
|
gptkb:health_services
gptkb:Precision_Medicine
|
|
gptkbp:is_supported_by
|
gptkb:cloud_computing
|
|
gptkbp:is_used_by
|
Pharmaceutical Companies
Biotechnology Companies
|
|
gptkbp:is_used_in
|
Virtual Screening
|
|
gptkbp:presented_by
|
Conferences
|
|
gptkbp:provides_support_for
|
Biomarker Discovery
|
|
gptkbp:reduces
|
Time to Market
|
|
gptkbp:research
|
Academic Institutions
|
|
gptkbp:supports
|
gptkb:Clinical_Trials
|
|
gptkbp:technique
|
Data-Driven Drug Design
|
|
gptkbp:trends
|
Healthcare Innovation
|
|
gptkbp:uses
|
gptkb:machine_learning
|
|
gptkbp:utilizes
|
Data Mining
|
|
gptkbp:bfsParent
|
gptkb:Deep_Mind
|
|
gptkbp:bfsLayer
|
5
|